GEnetic causes of Ventricular Arrhythmias in patients with first STEMI
The GEVAMI study is an ongoing nationwide prospective Danish case-control study among patients with first ST-Segment Elevation Myocardial Infarction (STEMI).
- Start Year
- Copenhagen University Hospital, Rigshospitalet and Novo Nordisk Foundation
- Study design
- Follow Up
- Participants are followed up continuously for 5 years by reviewing Danish registries to assess for all-cause mortality.
Jabbari, R., Glinge, C., Jabbari, J., Risgaard, B., Winkel, B. G., Terkelsen, C. J., Tilsted, H. H., Jensen, L. O., Hougaard, M., Haunsø, S., Engstrøm, T., Albert, C. M., & Tfelt-Hansen, J. (2017). A Common Variant in SCN5A and the Risk of Ventricular Fibrillation Caused by First ST-Segment Elevation Myocardial Infarction. PloS one, 12(1), e0170193. https://doi.org/10.1371/journal.pone.0170193
- Sources of Recruitment
Number of participants
- Number of participants
- Number of participants with biosamples
- Supplementary Information
- 257 cases (STEMI with VF) and 537 controls (STEMI without VF). Aged 18-80 years
Availability of data and biosamples
No coverage data about the variables classifications are available.